The Green Fund Inaugural Top 5 Industry Thought Leaders

Mark Bernberg17 Nov 3min read

Here at The Green Fund we often say that good management is the key to a good company. And here are 5 of the best in the game.

We only believe in, and invest in, companies that we see as having a very solid management team comprised of individuals with a proven track record. After all, a good ship is useless without a great captain.

Given the nascent nature of the cannabis industry—particularly here in Australia—it can be tough to separate the wheat from the chaff. New players are constantly emerging, and the industry itself is in a perpetual state of evolution.

The people with the best people win

David Ogilvy

That's why we've decided to release the first edition of our 'Top 5 Industry Leaders' to encapsulate and amplify the individuals that we see as being torchbearers for the Australian cannabis industry for years to come.

This is also the perfect time to sink your teeth into the industry, as things are finally starting to ramp up here in Australia, with the Australian Capital Territory recently legalizing cannabis for recreational use, and the medicinal industry continuing to grow exponentially.

According to FreshLeaf Analytics' Q3 2019 report, the number of new products available to Australian consumers has skyrocketed, growing by more than 40% in just 6 months.

Source: Freshleaf Analytics

Prescription numbers have also started to spike rapidly, with July alone seeing a 40% month on month increase in new patient approvals. For these reasons, FreshLeaf predicts that the Australian cannabis industry will hit $50 million in annualized revenue by the end of the year.

In our inaugural edition of the 'Top 5 Industry Leaders' book, we cover five key players in the Australian cannabis space, starting with Rhys Cohen, the director of Cannabis Consulting Australia, and now the principal consultant for Freshleaf Analytics. Rhys has played an integral role, particularly within medicinal cannabis here in Australia, namely for his work on the first White Paper on medicinal cannabis in Australia for the University of Sydney.

The second industry leader we've chosen is Paul Mavor. Paul is the founder of Health House International—which is one of the major wholesalers to Australian pharmacies for medicinal cannabis—a practising pharmacist of thirty years, and the director of Medical Cannabis Research Australia.

Our third industry leader is Dr. Stewart Washer. Dr. Washer has two decades of experience across medical technology, biotechnology, and agrifood companies, all prior to his entrance into the cannabis space. He has since gone on to become the founder of Zelda Therapeutics and Emerald Clinics while sitting on the board of Orthocell, Botanix Pharma and Cynata Therapeutics.

The fourth leader we've chosen within the cannabis space is Dr. Sud Agarwal. Dr. Agarwal has a medical background in anaesthesia, though he has since become an internationally recognized key opinion leader in cannabinoid medicines.

Over the course of 15 years—prior to his involvement with cannabis—Dr. Agarwal developed an impressive leadership track record, commercializing several healthcare companies while also becoming a successful property developer.

For our fifth and final industry leader, we've chosen Matt Callahan. Matt has nearly two decades of biotech experience and has served as the Executive Director of Orthocell for the past 13 years, while also being the President, Founder and CEO of iCeutica.

For the past six years, Matt has carved out an integral role within the cannabis space, serving as Executive Director of Botanix Pharma, a cannabis biotech focused on dermatology.

We often quote Wayne Gretsky here at The Green Fund when we say that "you have to skate where the puck is going." Well, it's a lot easier to know where the puck will be when the hockey player hitting it knows what they're doing.

Click on the link below to download the Green Fund's inaugural list of the 5 Australian Cannabis Industry thought leaders.

I want to learn more about…

CannabisLatest Stock Picks

I want to learn more about…

CannabisLatest Stock Picks

The Green Fund is Asia Pacific's preeminent media house, positioned at the forefront of the global cannabis industry. Committed to driving the industry forward, we spotlight the sector from all angles, explore the companies and the players making headlines, and cover some of the biggest cannabis companies in the world.

Any financial product advice provided in this website is general in nature. Content on this website does not take into account the objectives, financial situation or needs of any person, or purport to be comprehensive or constitute investment advice and should not be relied upon as such. You should consult a professional adviser to help you form your own opinion of the information and on whether the information is suitable for your individual objectives and needs as an investor. Where necessary, you should obtain a Product Disclosure Statement relating to the product and consider it before making any decision about whether to acquire the product. Read More

The content of this website does not constitute an offer by any representative of The Green Fund to buy or sell any financial products or services. Accordingly, reliance should not be placed solely on the content of this website, including any reports or recommendations, as the basis for making an investment, financial or other decision.

Recipients should not act on any report or recommendation issued by The Green Fund without first consulting a professional advisor in order to ascertain whether the recommendation (if any) is appropriate, having regard to their investment objectives, financial situation and particular needs. Any opinions expressed are subject to change without notice and may not be updated by The Green Fund.

The Green Fund believes the information contained in this website is correct. All information, opinions, conclusions, estimates, reports or recommendations provided are included with due care to its accuracy; however, no representation or warranty is made as to their accuracy, completeness, or reliability.

The Green Fund disclaims all liability and responsibility for any direct or indirect loss, or damage, which may be incurred by any recipient through any information, omission, error, or inaccuracy contained within any report or recommendation.

The views expressed in any report or recommendation are those of the analyst writing the report and no part of the compensation received by the analyst is directly related to the inclusion of specific recommendations or opinions.

The Green Fund and / or its associates may hold interests in the entities mentioned in any posted report or recommendation.

The Green Fund, or its representatives, may have relationships with the companies mentioned in posted reports - for example, acting as corporate advisor, dealer, broker, or holder of principal positions. The Green Fund and / or its representatives may also transact in those securities mentioned in the report, in a manner not consistent with recommendations made in the report.

Any recommendations or opinions stated in a report are done so based on assumptions made by The Green Fund.

The information provided in any report and on which it is based may include projections and / or estimates which constitute forward-looking statements. These expressed beliefs of future performance, events, results, or returns may not eventuate and as such no guarantee of these future scenarios is given or implied by The Green Fund. Any forward looking statements are subject to uncertainties and risks that may mean those forecasts made by The Green Fund are materially different to actual events. Show Less